However, it has been postulated that MMS (75 and 100 mg/kg, p.o.)could block dopamine D2 receptors and serotonin 5-HT2A/5-HT2C receptors thereby improve both positive and negative symptoms of psychosis in mice. This evidence concerns the gene DRD2 and psychotic disorder.